A Moderate-to-Severe Eczema Treatment | Adbry™ (tralokinumab-ldrm) | Adbry.com Skip to content

Adbry Is Now FDA-Approved

A new treatment for adults with moderate-to-severe atopic dermatitis (eczema)

Learn about Adbry
Icon of a play button

Watch how to
inject Adbry

Watch the video
Graphic of copay savings card for Adbry (tralokinumab-ldrm)

Learn about the
Adbry™ Copay Program

Learn about the program